Markets & Stocks

Stock quotes, market indicators and the latest market news.

Market Summary Market News Stock Quotes Market Movers
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alvotech - Ordinary Shares (NQ:ALVO)

5.610 -0.010 (-0.18%)
Delayed Quote Updated: 9:35 AM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,921
Open 5.610
Bid (Size) 5.600 (300)
Ask (Size) 5.620 (300)
Prev. Close 5.620
Today's Range 5.585 - 5.640
52wk Range 2.940 - 9.045
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Gapping stocks in Wednesday's session ↗
Via Chartmill
News headline image
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
From Alvotech
Via GlobeNewswire

Performance

YTD
+12.2%
+12.2%
1 Month
+7.1%
+7.1%
3 Month
+55.4%
+55.4%
6 Month
+53.7%
+53.7%
1 Year
-31.5%
-31.5%

More News

Read More
News headline image
Alvotech to present at upcoming investor conferences in September
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Alvotech Q2 2026 Earnings Call Transcript ↗
Via Benzinga
Topics Earnings
News headline image
Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
From Alvotech
Via GlobeNewswire
News headline image
Alvotech to Report Financial Results for H1 2026
From Alvotech
Via GlobeNewswire
News headline image
Alvotech announces successful closure of FDA inspection of manufacturing facility
From Alvotech
Via GlobeNewswire
News headline image
Alvotech further strengthens liquidity by securing term loan facility of $75 million
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement
From Alvotech
Via GlobeNewswire
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
From Alvotech
Via GlobeNewswire
News headline image
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Alvotech Hits Critical Inflection as Biosimilar Pipeline Nears FDA Decisions ↗
Via MarketBeat
News headline image
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®
From Alvotech
Via GlobeNewswire
News headline image
Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End ↗
Via MarketBeat
News headline image
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
From Alvotech
Via GlobeNewswire
News headline image
Main Results of 2026 Annual and Extraordinary General Meeting
From Alvotech
Via GlobeNewswire
News headline image
Alvotech to present at upcoming investor conferences in June
From Alvotech
Via GlobeNewswire
News headline image
Alvotech (ALVO) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
Topics Bonds
News headline image
Alvotech Plans June FDA Resubmissions, Sees Biosimilar Approvals by Year-End ↗
Via MarketBeat
News headline image
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
From Alvotech
Via GlobeNewswire

Frequently Asked Questions

Is Alvotech - Ordinary Shares publicly traded?
Yes, Alvotech - Ordinary Shares is publicly traded.
What exchange does Alvotech - Ordinary Shares trade on?
Alvotech - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alvotech - Ordinary Shares?
The ticker symbol for Alvotech - Ordinary Shares is ALVO on the Nasdaq Stock Market
What is the current price of Alvotech - Ordinary Shares?
The current price of Alvotech - Ordinary Shares is 5.610
When was Alvotech - Ordinary Shares last traded?
The last trade of Alvotech - Ordinary Shares was at 10/02/26 09:35 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.